Literature DB >> 20079538

Reproducibility of retinal nerve fiber layer and macular thickness measurement with the RTVue-100 optical coherence tomograph.

Anita Garas1, Péter Vargha, Gábor Holló.   

Abstract

PURPOSE: To evaluate the reproducibility of peripapillary retinal nerve fiber layer thickness (RNFLT) and ganglion cell complex (GCC) measurements made with the RTVue-100 Fourier-domain optical coherence tomography (OCT) device (Optovue, Inc., Fremont, CA) and to determine the influence of 4 factors: pupil dilation, subject age, experience in imaging examinations, and glaucoma severity.
DESIGN: Prospective study for evaluation of a diagnostic test. PARTICIPANTS: Thirty-seven hospital-based participants (14 normal and ocular hypertensive subjects, 11 patients with moderate and 12 with severe glaucoma), all experienced in imaging examinations, and 40 consecutive screening trial participants lacking such experience.
METHODS: One eye of all participants was imaged 5 times. For the hospital-based participants, on the same day the measurement series was repeated after pupil dilation. For determination of intersession reproducibility, measurements were performed again 3 months later. MAIN OUTCOME MEASURES: Intrasession and intersession coefficient of variation (CV), intraclass correlation coefficient (ICC), intratest variability, and test-retest variability.
RESULTS: For the average and quadrant RNFLT parameters and the GCC parameters, intrasession ICC varied between 93.9% and 99.0%, intrasession CV between 1.95% and 5.69%, and intratest variability varied between 3.11 and 9.13 microm. Most thickness values, all intrasession CV and intratest variability values, and the signal strength index were not changed significantly after pupil dilation. Intrasession CV of the 16 peripapillary RNFLT sectors varied between 4.90% and 11.66%. Most intrasession CV values increased significantly with increased disease severity, but intratest variability for average RNFLT and the quadrant RNFLT parameters, which are used for statistical comparison with the normative database, were unaffected by the severity of glaucoma. Patient age and experience in imaging examinations had no influence on intrasession CV. Intratest variability and intrasession CV represented 79.1% to 98.6% and 77.1% to 95.0% of test-retest variability and intervisit CV, respectively, for the average and quadrant RNFLT and the GCC parameters.
CONCLUSIONS: Intrasession and intersession reproducibility of RNFLT and GCC measurements with the RTVue-100 OCT are satisfactory for diagnostic purposes, both in normals and in patients with different glaucoma severity. Pupil dilation, age, and experience in imaging examinations did not influence reproducibility in a clinically significant manner. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references. Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20079538     DOI: 10.1016/j.ophtha.2009.08.039

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  64 in total

1.  Detection of macular and circumpapillary structural loss in normal hemifield areas of glaucomatous eyes with localized visual field defects using spectral-domain optical coherence tomography.

Authors:  Jung Hwa Na; Michael S Kook; Youngrok Lee; Sung Jin Yu; Jaewan Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

2.  Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.

Authors:  Robert N Weinreb; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-04       Impact factor: 4.799

3.  A study of retinal parameters measured by optical coherence tomography in patients with multiple sclerosis.

Authors:  Sai-Jing Hu; Yi-An You; Yi Zhang
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

Review 4.  Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis.

Authors:  Kyung Rim Sung; Jong S Kim; Gadi Wollstein; Lindsey Folio; Michael S Kook; Joel S Schuman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

5.  Comparison of retinal nerve fiber layer thickness measurement bias and imprecision across three spectral-domain optical coherence tomography devices.

Authors:  Nancy M Buchser; Gadi Wollstein; Hiroshi Ishikawa; Richard A Bilonick; Yun Ling; Lindsey S Folio; Larry Kagemann; Robert J Noecker; Eiyass Albeiruti; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

6.  Comparison of macular ganglion cell complex thickness to total retinal thickness ratio between Hungarian and Japanese eyes.

Authors:  Yoshiyuki Kita; Farzaneh Naghizadeh; Ritsuko Kita; Goji Tomita; Gábor Holló
Journal:  Jpn J Ophthalmol       Date:  2013-08-27       Impact factor: 2.447

7.  Study of Retinal Nerve Fibre Layer Thickness in Patients with Diabetes Mellitus Using Fourier Domain Optical Coherence Tomography.

Authors:  Renu Dhasmana; Sonal Sah; Neeti Gupta
Journal:  J Clin Diagn Res       Date:  2016-07-01

8.  Intra- and inter-visit reproducibility of ganglion cell-inner plexiform layer measurements using handheld optical coherence tomography in children with optic pathway gliomas.

Authors:  Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa
Journal:  Am J Ophthalmol       Date:  2014-07-25       Impact factor: 5.258

9.  Progressive Macula Vessel Density Loss in Primary Open-Angle Glaucoma: A Longitudinal Study.

Authors:  Takuhei Shoji; Linda M Zangwill; Tadamichi Akagi; Luke J Saunders; Adeleh Yarmohammadi; Patricia Isabel C Manalastas; Rafaella C Penteado; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2017-07-20       Impact factor: 5.258

Review 10.  Optical coherence tomography--current and future applications.

Authors:  Mehreen Adhi; Jay S Duker
Journal:  Curr Opin Ophthalmol       Date:  2013-05       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.